31 related articles for article (PubMed ID: 7903459)
1. Repeated Dosing of Ketamine in the Forced Swim Test: Are Multiple Shots Better Than One?
Weston RG; Fitzgerald PJ; Watson BO
Front Psychiatry; 2021; 12():659052. PubMed ID: 34045982
[TBL] [Abstract][Full Text] [Related]
2. Rodent ketamine depression-related research: Finding patterns in a literature of variability.
Polis AJ; Fitzgerald PJ; Hale PJ; Watson BO
Behav Brain Res; 2019 Dec; 376():112153. PubMed ID: 31419519
[TBL] [Abstract][Full Text] [Related]
3. The impact of sex as a biological variable in the search for novel antidepressants.
Williams AV; Trainor BC
Front Neuroendocrinol; 2018 Jul; 50():107-117. PubMed ID: 29859882
[TBL] [Abstract][Full Text] [Related]
4. Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation.
Reus GZ; de Moura AB; Silva RH; Resende WR; Quevedo J
Curr Neuropharmacol; 2018 Mar; 16(3):297-307. PubMed ID: 28676011
[TBL] [Abstract][Full Text] [Related]
5. New targets for rapid antidepressant action.
Machado-Vieira R; Henter ID; Zarate CA
Prog Neurobiol; 2017 May; 152():21-37. PubMed ID: 26724279
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the antidepressant response and treatment resistance.
Levinstein MR; Samuels BA
Front Behav Neurosci; 2014; 8():208. PubMed ID: 25018708
[TBL] [Abstract][Full Text] [Related]
7. NMDA Receptor Antagonists for Treatment of Depression.
Ates-Alagoz Z; Adejare A
Pharmaceuticals (Basel); 2013 Apr; 6(4):480-99. PubMed ID: 24276119
[TBL] [Abstract][Full Text] [Related]
8. Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
Carlson PJ; Diazgranados N; Nugent AC; Ibrahim L; Luckenbaugh DA; Brutsche N; Herscovitch P; Manji HK; Zarate CA; Drevets WC
Biol Psychiatry; 2013 Jun; 73(12):1213-21. PubMed ID: 23540908
[TBL] [Abstract][Full Text] [Related]
9. The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.
Sani G; Serra G; Kotzalidis GD; Romano S; Tamorri SM; Manfredi G; Caloro M; Telesforo CL; Caltagirone SS; Panaccione I; Simonetti A; Demontis F; Serra G; Girardi P
CNS Drugs; 2012 Aug; 26(8):663-90. PubMed ID: 22784018
[TBL] [Abstract][Full Text] [Related]
10. Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.
Mathews DC; Henter ID; Zarate CA
Drugs; 2012 Jul; 72(10):1313-33. PubMed ID: 22731961
[TBL] [Abstract][Full Text] [Related]
11. Translating glutamate: from pathophysiology to treatment.
Javitt DC; Schoepp D; Kalivas PW; Volkow ND; Zarate C; Merchant K; Bear MF; Umbricht D; Hajos M; Potter WZ; Lee CM
Sci Transl Med; 2011 Sep; 3(102):102mr2. PubMed ID: 21957170
[TBL] [Abstract][Full Text] [Related]
12. Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.
Machado-Vieira R; Zarate CA
Depress Anxiety; 2011 Apr; 28(4):267-81. PubMed ID: 21456037
[TBL] [Abstract][Full Text] [Related]
13. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Diazgranados N; Ibrahim L; Brutsche NE; Newberg A; Kronstein P; Khalife S; Kammerer WA; Quezado Z; Luckenbaugh DA; Salvadore G; Machado-Vieira R; Manji HK; Zarate CA
Arch Gen Psychiatry; 2010 Aug; 67(8):793-802. PubMed ID: 20679587
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic targets for mood disorders.
Machado-Vieira R; Salvadore G; DiazGranados N; Ibrahim L; Latov D; Wheeler-Castillo C; Baumann J; Henter ID; Zarate CA
ScientificWorldJournal; 2010 Apr; 10():713-26. PubMed ID: 20419280
[TBL] [Abstract][Full Text] [Related]
15. The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.
Machado-Vieira R; Manji HK; Zarate CA
Neuroscientist; 2009 Oct; 15(5):525-39. PubMed ID: 19471044
[TBL] [Abstract][Full Text] [Related]
16. Ketamine and the next generation of antidepressants with a rapid onset of action.
Machado-Vieira R; Salvadore G; Diazgranados N; Zarate CA
Pharmacol Ther; 2009 Aug; 123(2):143-50. PubMed ID: 19397926
[TBL] [Abstract][Full Text] [Related]
17. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Maeng S; Zarate CA
Curr Psychiatry Rep; 2007 Dec; 9(6):467-74. PubMed ID: 18221626
[TBL] [Abstract][Full Text] [Related]
18. Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.
Meloni D; Gambarana C; De Montis MG; Dal Prá P; Taddei I; Tagliamonte A
Pharmacol Biochem Behav; 1993 Oct; 46(2):423-6. PubMed ID: 7903459
[TBL] [Abstract][Full Text] [Related]
19. Long-term imipramine effects are prevented by NMDA receptor blockade.
De Montis MG; Gambarana C; Meloni D; Taddei I; Tagliamonte A
Brain Res; 1993 Mar; 606(1):63-7. PubMed ID: 8096430
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
